Innoveren Scientific Inc (Innoveren Scientific), formerly H-CYTE Inc, is a medical device company. The company operates in designing and marketing medical devices for commercial use. It offers DenerveX device, a disposable single-use kit for the treatment of various medical applications including pain relief from chronic back pain caused by facet joint disorders. The company serves healthcare providers, physicians, and third-party payors. It has operations throughout the US and Europe. Innoveren Scientific is headquartered in Tampa, Florida, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Innoveren Scientific Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Innoveren Scientific Inc Company Overview
Innoveren Scientific Inc Company Snapshot
Innoveren Scientific Inc Pipeline Products and Ongoing Clinical Trials Overview
Innoveren Scientific Inc - Locations And Subsidiaries
Head Office
Recent Developments
Innoveren Scientific Inc, Recent Developments
Mar 06, 2024: Innoveren Scientific Announces 510(k) Submission for SkinDisc Lite
Jun 29, 2021: H-CYTE announces publication of positive real-world data relating to the use of innovative treatment (PRP-PBMC) aimed at helping improve overall lung health
Jul 30, 2019: H-CYTE bolsters Board of Directors with appointment of Dr. Atta Behfar to its Board of Directors
Jul 29, 2019: H-CYTE bolsters Board of Directors With appointment of Dr. Andre Terzic to Board of Directors
Jul 12, 2019: Medovex announces name change to H-CYTE and new ticker symbol
Jun 24, 2019: Medovex’s transition to H-CYTE underscores biotechnology focus